Key result
Cardiac rehabilitation referral was not associated with a reduction in the combined endpoint of death or HF hospitalization after baseline adjustment.
Why the study?
The study aimed to assess the referral rate to cardiac rehabilitation, the clinical profile of referred versus nonreferred patients, and the association between referral and clinical events in Spanish HF units.
Does referral to cardiac rehabilitation reduce all-cause death or heart failure hospitalization in patients with heart failure treated in accredited Spanish heart failure units?
Cohort (n=2,236)
Yes
Does referral to cardiac rehabilitation reduce all-cause death or heart failure hospitalization in patients with heart failure treated in accredited Spanish heart failure units?
In Spanish heart failure units, cardiac rehabilitation referral is low (9.8%), preferentially targets younger patients with ischemic HFrEF and fewer comorbidities, and shows no independent association with reduced death or HF hospitalization after baseline adjustment.
Answers are grounded in this paper and cite their sources.
No adjusted outcome benefit seen; leaves open efficacy of cardiac rehabilitation in broader HF populations.
To assess the referral rate to cardiac rehabilitation (CR), the clinical profile of referred vs nonreferred patients, and the association between referral and clinical events in Spanish heart failure (HF) units. The SEC-EXCELENTE-IC registry is a prospective, multicenter observational cohort of patients with HF in units accredited by the Spanish Society of Cardiology. Patients were classified according to CR referral and were followed up for up to 400 days for all-cause death, HF hospitalization or decompensation, and the combined endpoint of death or HF hospitalization, with outcomes analyzed using Cox regression. Of 2236 patients, 219 (9.8%) were referred to CR. Referred patients were younger (65.2 ± 11.7 vs 71.7 ± 12.2 years), more often male (73.5% vs 63.2%) and more frequently had an ischemic etiology (50.5% vs 28.8%), fewer comorbidities and more frequent use of quadruple therapy (59.4% vs 46.0%); 74.4% had HF with reduced ejection fraction (11.9% had HF with preserved ejection fraction, and 13.7% HF with mildly reduced ejection fraction). The lower crude rate of the combined endpoint (HR, 0.75; 95%CI, 0.56-1.01) was no longer observed after adjustment (HR, 0.99; 95%CI, 0.71-1.38), with consistent findings in sensitivity analyses. CR referral was infrequent and preferentially directed toward younger patients with ischemic HF with reduced ejection fraction, a lower comorbidity burden, and optimized therapy, whereas older patients, patients with multimorbidity, and those with HF with preserved ejection fraction remained underrepresented. The lower crude event rate was no longer observed after adjustment for measured baseline characteristics, and the observational design does not allow conclusions on the effect of CR itself.
No takes yet. Share an insight, caveat, or question.
Esteban‐Fernández et al. (2026) conducted a cohort in Heart failure (n=2,236). Referral to cardiac rehabilitation (CR) vs. Non-referral to cardiac rehabilitation was evaluated on Combined endpoint of all-cause death or heart failure hospitalization (HR 0.99, 95% CI 0.71-1.38). Cardiac rehabilitation referral was not associated with a reduction in the combined endpoint of death or HF hospitalization after baseline adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: